What is NDC 70771-1906?

70771-1906 is the product NDC for dasatinib, Dasatinib 140 mg/1 tablet, listed with the FDA by Zydus Lifesciences Limited. It has 1 package NDC, shown above in 10- and 11-digit form.

Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for dasatinib?

95 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

dasatinib NDC 70771-1906 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70771-1906Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70771-1906Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70771-1906-3	7077119060370771190603	30 TABLET in 1 BOTTLE (70771-1906-3)Marketed from Mar 3, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): dasatinib
Generic name (nonproprietary): dasatinib
Active ingredients: Dasatinib — 140 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Zydus Lifesciences LimitedNDC labeler code 70771
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218719
Marketing start: Mar 3, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 3A4 Inhibitors (Mechanism)Protein Kinase Inhibitors (Mechanism)
Identifiers: Product ID 70771-1906_571889d7-845d-4fed-8d7d-6470d4d36fa1SPL ID 571889d7-845d-4fed-8d7d-6470d4d36fa1SPL set ID 4eed6b7b-a09d-4d2e-a345-968dd68323bcRxCUI 643105, 643107, 643109, 799047, 1045402, 1045406UNII RBZ1571X5HUPC 0370710174439, 0370710174163, 0370710174262, 0370710174637, 0370710174361, 0370710174538
Pharmacologic class: Kinase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771190603 followed by a unit qualifier and the quantity

Package 70771-1906-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 4, 2025.

Full label on DailyMed (opens in a new tab)

About NDC 70771-1906

What is NDC 70771-1906?: 70771-1906 is the product NDC for dasatinib, Dasatinib 140 mg/1 tablet, listed with the FDA by Zydus Lifesciences Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: dasatinib.
What is the active ingredient?: Dasatinib.
Who is the labeler?: Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for dasatinib?: 95 other product NDCs are listed under this name. See all dasatinib NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other dasatinib NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Dasatinib	Dasatinib 20 mg/1	Tablet, Film coatedOral	Quallent Pharmaceuticals Health LLC	82009-192	82009-0192-60
Dasatinib	Dasatinib 100 mg/1	Tablet, Film coatedOral	Quallent Pharmaceuticals Health LLC	82009-196	82009-0196-30
Dasatinib	Dasatinib 50 mg/1	Tablet, Film coatedOral	Quallent Pharmaceuticals Health LLC	82009-193	82009-0193-60
Dasatinib	Dasatinib 70 mg/1	Tablet, Film coatedOral	Quallent Pharmaceuticals Health LLC	82009-194	82009-0194-60
Dasatinib	Dasatinib 80 mg/1	Tablet, Film coatedOral	Quallent Pharmaceuticals Health LLC	82009-195	82009-0195-30
Dasatinib	Dasatinib 140 mg/1	Tablet, Film coatedOral	Quallent Pharmaceuticals Health LLC	82009-197	82009-0197-30
Dasatinib	Dasatinib 20 mg/1	TabletOral	Novadoz Pharmaceuticals LLC	72205-319	72205-0319-60
Dasatinib	Dasatinib 100 mg/1	TabletOral	Novadoz Pharmaceuticals LLC	72205-323	72205-0323-30
Dasatinib	Dasatinib 50 mg/1	TabletOral	Novadoz Pharmaceuticals LLC	72205-320	72205-0320-60
Dasatinib	Dasatinib 70 mg/1	TabletOral	Novadoz Pharmaceuticals LLC	72205-321	72205-0321-60

All 96 dasatinib NDCs

Other NDCs under ANDA 218719

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218719
Product	Strength	Form · route	Labeler	Product NDC
dasatinib	Dasatinib 50 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	70710-1742
dasatinib	Dasatinib 20 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	70710-1741
dasatinib	Dasatinib 140 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	70710-1746
dasatinib	Dasatinib 70 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	70710-1743
dasatinib	Dasatinib 80 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	70710-1744
dasatinib	Dasatinib 100 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	70710-1745
dasatinib	Dasatinib 80 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1904
dasatinib	Dasatinib 20 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1901
dasatinib	Dasatinib 50 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1902
dasatinib	Dasatinib 70 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1903
dasatinib	Dasatinib 100 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1905